Remove initiatives foundation
article thumbnail

Novo Nordisk Foundation sets up airborne infection vaccine initiative

Pharmaceutical Technology

The Novo Nordisk Foundation has invested Dkr1.8bn in the initiative to develop vaccines for various airborne infection diseases.

article thumbnail

Novo Nordisk Foundation establishes new vaccine initiative worth $260m

Pharma Times

The Novo Nordisk Foundation has committed $260m to establish a new state-of-the-art research and vaccine development initiative to help combat deadly airborne infections. The initiative aims to create new or improved vaccines for deadly respiratory diseases, including tuberculosis (TB) and influenza. million deaths every year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Diversity initiative backed by Bristol Myers Squibb Foundation, Gilead picks physicians for training

Outsourcing Pharma

A $114m diversity in clinical trials initiative supported by the Bristol Myers Squibb Foundation (BMSF) and Gilead Sciences has selected 64 physicians for awards.

52
article thumbnail

Gates Foundation spends $40M to boost mRNA vaccine production in Africa and beyond

Fierce Pharma

Following similar initiatives to bolster mRNA vaccine production and access in Africa, the Bill & Melinda Gates Foundation is providing new funding to a clutch of drugmakers.

Vaccines 138
article thumbnail

Owlstone secures $6.5M for breath-based diagnostics for infectious disease

pharmaphorum

Owlstone Medical has secured a $5 million equity investment and initial $1.5 million grant funding, committed by the Bill and Melinda Gates Foundation, for development of breath-based diagnostic solutions to improve outcomes in the developing world.

69
article thumbnail

Novo Nordisk Foundation establishes new vaccine initiative worth $260m

Pharma Times

NIVI aims to create new or improve vaccines to combat deadly airborne infections - News - PharmaTimes

article thumbnail

Novo Nordisk Foundation puts $25m into AMR programme

pharmaphorum

Novo Nordisk Foundation has put $25m of funding into CARB-X, an initiative that aims to tackle antimicrobial resistance (AMR).

105
105